While reporting financial results for the second quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) raised its adjusted earnings guidance for the full year 2024, while trimming annual net sales outlook.
from RTT - Earnings https://ift.tt/UadkA8I
via IFTTT
No comments:
Post a Comment